StockGuru News: Lotus Pharmaceuticals Releases Audited Annual Report With $36 Million in Revenues and $4.1 Million in Net Profits
Lotus Pharmaceuticals Releases Audited Annual Report With $36 Million in Revenues and $4.1 Million in Net Profits Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) BEIJING, April 17, 2007 (PRIME NEWSWIRE) — Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB - News) released its 2006 audited annual report, revealing gross revenues of $36 million, net profits of $4.1 million and net assets of $20.6 million. Mr. Adam Wasserman, Chief Financial Officer, summarized the Form 10-KSB filed today: “Total revenues for the year ended December 31, 2006 were $36,207,689 as compared to total revenues of $18,345,841 for the year ended December 31, 2005, an increase of $17,861,848…